N-3 fatty acids and cardiovascular risk

Mark NAUNTON

doi:10.1056/NEJMoa1205409

N-3 fatty acids and cardiovascular risk

Mark NAUNTON

Pharmacy

Research output: Contribution to journal › Article › peer-review

497 Citations (Scopus)

Abstract

N-3 polyunsaturated fatty acids may have benefi cial effects on reducing the risk of cardiovascular disease as large trials have demonstrated benefi t in secondary prevention of cardiovascular disease following myocardial infarction and heart failure.

Original language	English
Pages (from-to)	153-154
Number of pages	2
Journal	Journal of Pharmacy Practice and Research
Volume	43
Issue number	2
DOIs	https://doi.org/10.1056/NEJMoa1205409
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJMoa1205409

Cite this

@article{76a6e471438d470aafcefb3551d76eee,

title = "N-3 fatty acids and cardiovascular risk",

abstract = "N-3 polyunsaturated fatty acids may have benefi cial effects on reducing the risk of cardiovascular disease as large trials have demonstrated benefi t in secondary prevention of cardiovascular disease following myocardial infarction and heart failure.",

keywords = "fatty acids, cardiovascular risk, risk prevention",

author = "Mark NAUNTON",

year = "2013",

doi = "10.1056/NEJMoa1205409",

language = "English",

volume = "43",

pages = "153--154",

journal = "Journal of Pharmacy Practice and Research",

issn = "1445-937X",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - N-3 fatty acids and cardiovascular risk

AU - NAUNTON, Mark

PY - 2013

Y1 - 2013

N2 - N-3 polyunsaturated fatty acids may have benefi cial effects on reducing the risk of cardiovascular disease as large trials have demonstrated benefi t in secondary prevention of cardiovascular disease following myocardial infarction and heart failure.

AB - N-3 polyunsaturated fatty acids may have benefi cial effects on reducing the risk of cardiovascular disease as large trials have demonstrated benefi t in secondary prevention of cardiovascular disease following myocardial infarction and heart failure.

KW - fatty acids

KW - cardiovascular risk

KW - risk prevention

U2 - 10.1056/NEJMoa1205409

DO - 10.1056/NEJMoa1205409

M3 - Article

SN - 1445-937X

VL - 43

SP - 153

EP - 154

JO - Journal of Pharmacy Practice and Research

JF - Journal of Pharmacy Practice and Research

IS - 2

ER -

N-3 fatty acids and cardiovascular risk

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this